1
|
Meng L, Song Z, Liu A, Dahmen U, Yang X, Fang H. Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases, Metabolic Disorders and Cancers. Front Immunol 2021; 12:681810. [PMID: 34295331 PMCID: PMC8290185 DOI: 10.3389/fimmu.2021.681810] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Accepted: 06/08/2021] [Indexed: 01/11/2023] Open
Abstract
Inflammation, which is induced by the immune response, is recognized as the driving factor in many diseases, including infections and inflammatory diseases, metabolic disorders and cancers. Genetic variations in pivotal genes associated with the immune response, particularly single nucleotide polymorphisms (SNPs), may account for predisposition and clinical outcome of diseases. Lipopolysaccharide (LPS)-binding protein (LBP) functions as an enhancer of the host response to LPS, the main component of the outer membrane of gram-native bacteria. Given the crucial role of LBP in inflammation, we will review the impact of SNPs in the LBP gene on infections and inflammatory diseases, metabolic disorders and cancers.
Collapse
Affiliation(s)
- Leilei Meng
- Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China
| | - Zichen Song
- Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China
| | - Anding Liu
- Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Uta Dahmen
- Experimental Transplantation Surgery, Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena, Jena, Germany
| | - Xiao Yang
- Experimental Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Haoshu Fang
- Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China
| |
Collapse
|
2
|
van Rijn BB, Bruinse HW, Veerbeek JH, Post Uiterweer ED, Koenen SV, van der Bom JG, Rijkers GT, Roest M, Franx A. Postpartum Circulating Markers of Inflammation and the Systemic Acute-Phase Response After Early-Onset Preeclampsia. Hypertension 2015; 67:404-14. [PMID: 26711734 DOI: 10.1161/hypertensionaha.115.06455] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2015] [Accepted: 11/30/2015] [Indexed: 01/18/2023]
Abstract
Preeclampsia is an inflammatory-mediated hypertensive disorder of pregnancy and seems to be an early indicator of increased cardiovascular risk, but mechanisms underlying this association are unclear. In this study, we identified levels of circulating inflammatory markers and dynamic changes in the systemic acute-phase response in 44 women with a history of severe early-onset preeclampsia, compared with 29 controls with only uneventful pregnancies at 1.5 to 3.5 years postpartum. Models used were in vivo seasonal influenza vaccination and in vitro whole-blood culture with T-cell stimulants and the toll-like receptor-4 ligand lipopolysaccharide. Outcome measures were C-reactive protein, interleukin-6 (IL-6), IL-18, fibrinogen, myeloperoxidase, and a panel of 13 cytokines representative of the innate and adaptive inflammatory response, in addition to established cardiovascular markers. The in vivo acute-phase response was higher for women with previous preeclampsia than that for controls without such a history, although only significant for C-reactive protein (P=0.04). Preeclampsia was associated with higher IL-1β (P<0.05) and IL-8 (P<0.01) responses to T-cell activation. Hierarchical clustering revealed 2 distinct inflammatory clusters associated with previous preeclampsia: an adaptive response cluster associated with increased C-reactive protein and IL-6 before and after vaccination, increased weight, and low high-density lipoprotein cholesterol; and a toll-like receptor-4 mediated the cluster associated with increased IL-18 before and after vaccination but not associated with other cardiovascular markers. Furthermore, we found interactions between previous preeclampsia, common TLR4 gene variants, and the IL-18 response to vaccination. In conclusion, preeclampsia is associated with alterations in the inflammatory response postpartum mostly independent of other established cardiovascular risk markers.
Collapse
Affiliation(s)
- Bas B van Rijn
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.).
| | - Hein W Bruinse
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| | - Jan H Veerbeek
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| | - Emiel D Post Uiterweer
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| | - Steven V Koenen
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| | - Johanna G van der Bom
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| | - Ger T Rijkers
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| | - Mark Roest
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| | - Arie Franx
- From the Division of Woman and Baby (B.B.v.R., H.W.B., J.H.V., E.D.P.U., S.V.K., A.F.) and Laboratory for Clinical Chemistry and Hematology, University Medical Center Utrecht (M.R.), Utrecht, The Netherlands; Centre for Trophoblast Disease, University of Cambridge, Cambridge, United Kingdom (J.H.V.); Department of Clinical Epidemiology and Hematology, Leiden University Medical Center, Leiden, The Netherlands (J.G.v.d.B.); Department of Medical Microbiology, St Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands (G.T.R.); Department of Science, University College Roosevelt, Middelburg, The Netherlands (G.T.R.); and Academic Unit of Human Development and Health, University of Southampton, Southampton, United Kingdom (B.B.v.R.)
| |
Collapse
|